Alexander (Bo) Cumbo
Board Member
Solid Biosciences Inc. (SLDB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alexander (Bo) Cumbo
Alexander (Bo) Cumbo is recorded as CEO and Board Member at Solid Biosciences Inc. (SLDB). Solid Biosciences Inc. reported in an 8-K filed December 5, 2022 that Alexander (Bo) Cumbo was appointed President and Chief Executive Officer, effective December 2, 2022. Solid Biosciences Inc. reported in an 8-K filed September 30, 2022 that Alexander (Bo) Cumbo was appointed board of directors. Solid Biosciences Inc. reported in an 8-K filed September 30, 2022 that Alexander (Bo) Cumbo was appointed President and Chief Executive Officer.
“On November 30, 2022, the Board appointed Alexander (Bo) Cumbo as the Company's President and Chief Executive Officer and elected Mr. Cumbo as a member of the Board, in each case, subject to and contingent and effective upon the closing of the Acquisition (the "Effective Date").”
“It is expected that, subject to and effective upon the closing of the Merger, Alexander (Bo) Cumbo, the current President and Chief Executive Officer of AavantiBio, will be appointed as the President and Chief Executive Officer of the Company, and Mr. Cumbo and Adam Koppel, Managing Director of Bain Capital Life Sciences, will join the board of directors (the "Board") of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-12-02–present
-
Current
2022-12-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Solid Biosciences Inc.
Other people whose current roles at this company are on record from its filings.
- Alexander Cumbo CEO, Board Member
- Bo Cumbo CEO, Board Member
- Ian F. Smith Chairman
- Kevin Tan CFO, Chief Accounting Officer
- Stephen J. DiPalma CFO
- David Tyronne Howton COO
- Paul Herzich CTO
- Adam Koppel Board Member
- Adam Koppel, M.D., Ph.D. Board Member
- Adam Stone Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.